WINTON GROUP Ltd - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 42 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q2 2020$1,130,000
+45.8%
824,750
+21.3%
0.03%
+45.0%
Q1 2020$775,000
-51.3%
680,119
-2.5%
0.02%
-9.1%
Q4 2019$1,591,000
+8273.7%
697,771
+3022.6%
0.02%
Q3 2019$19,00022,3460.00%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q3 2020
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders